VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Luzhou Laojiao Co., Ltd. vs GSK plc
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Luzhou Laojiao Co., Ltd.
000568.SZ · Shenzhen Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Luzhou Laojiao Co., Ltd.'s moat claims, evidence, and risks.
View 000568.SZ analysisGSK plc
GSK · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Luzhou Laojiao Co., Ltd. leads (73 / 100 vs 62 / 100 for GSK plc).
- Segment focus: Luzhou Laojiao Co., Ltd. has 2 segments (91.5% in Mid- and high-end baijiu); GSK plc has 3 segments (37.6% in Specialty Medicines).
- Moat breadth: Luzhou Laojiao Co., Ltd. has 5 moat types across 3 domains; GSK plc has 4 across 3.
Primary market context
Luzhou Laojiao Co., Ltd.
Mid- and high-end baijiu
Premium baijiu (strong-aroma) in China
China (primarily); limited exports
Consumers (personal consumption) and gifting/banquet channels via distributors/retail
Distiller / brand owner
91.5%
GSK plc
Specialty Medicines
Branded specialty pharmaceuticals (HIV, oncology, immunology/respiratory)
Global
Hospitals, specialist physicians, payers
Innovator & branded manufacturer
37.6%
Side-by-side metrics
Moat coverage
Shared moat types
Luzhou Laojiao Co., Ltd. strengths
GSK plc strengths
Segment mix
Luzhou Laojiao Co., Ltd. segments
Full profile >Mid- and high-end baijiu
Oligopoly
Other baijiu (mainstream/value)
Competitive
GSK plc segments
Full profile >Vaccines
Oligopoly
Specialty Medicines
Oligopoly
General Medicines
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.